# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
AnPac Bio-Medical Science (NASDAQ:ANPC) reported quarterly losses of $(0.04) per share. This is a 99.46 percent increase over l...
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quar...
AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) ("AnPac Bio," the "Company" or "we"), a company with ...
Health institutions including hospitals have reported that 2,837 individuals within the study were identified as cancer, pre-...